BMG7496G1033 - Common Stock

189.08 **-5.59 (-2.87%) **

After market: 190.02 +0.94 (+0.5%)

Overall **RNR** gets a fundamental rating of **3** out of 10. We evaluated **RNR** against 141 industry peers in the **Insurance** industry. **RNR** has a bad profitability rating. Also its financial health evaluation is rather negative. **RNR** has a correct valuation and a medium growth rate.

*Note: RNR has only limited data available, so a full analysis was not possible, which makes the total rating unfair.*

The **Forward Price/Earnings Ratio** of **6.53** indicates a rather cheap valuation of **RNR**.

The low **PEG Ratio**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

With a **Price/Earnings Ratio** of **16.12**, **RNR** is valued correctly.

With a price book ratio of **1.62**, **RNR** is valued correctly.

Compared to an average industry **Price/Earning Ratio** of **10.54**, **RNR** is valued slightly more expensive.

When comparing the price book ratio of **RNR** to the average industry price book ratio of 1.10, **RNR** is valued more expensive than its industry peers.

Price/Earnings (16.12) VS Industry: 29% outperformed.

739.33

1.18

Price/Book (1.62) VS Industry: 30% outperformed.

75.45

0.08

The **Earnings Per Share** has grown by an impressive **140.86%** over the past year.

The **Earnings Per Share** is expected to grow by **66.60%** on average over the next 5 years. This is a very strong growth

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

Measured over the past 5 years, **RNR** shows a quite strong growth in **Revenue**. The Revenue has been growing by **19.63%** on average per year.

Based on estimates for the next 5 years, **RNR** will show a quite strong growth in **Revenue**. The Revenue will grow by **12.86%** on average per year.

Looking at the last year, **RNR** shows a small growth in **Revenue**. The Revenue has grown by **3.44%** in the last year.

The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | N/A | -8.37% | 140.86% | 258.79% | 102.36% | 66.6% | N/A |

Revenue | 19.63% | 6.87% | 3.44% | 24.53% | 13.98% | 12.86% | N/A |

With a Debt to Equity ratio of **0.19**, **RNR** is doing better than the averages in the industry. The industry average is at **0.38**.

Compared to an average industry Current Ratio of 1.15, **RNR** is worse placed to pay its short term obligations than its industry peers.

When comparing the Quick Ratio of **RNR** to the average industry Current Ratio of **1.15**, **RNR** is less able to pay its short term obligations than its industry peers.

Based on the Altman-Z score of **0.52**, we must say that **RNR** is in the distress zone and has some risk of bankruptcy.

Compared to an average industry Altman-Z score of **0.65**, **RNR** is in worse financial health than its industry peers.

Debt/Equity (0.19) VS Industry: 77% outperformed.

4.94

0.00

Quick Ratio (0.69) VS Industry: 29% outperformed.

0.03

8.17

Current Ratio (0.69) VS Industry: 29% outperformed.

0.03

8.17

Altman-Z (0.52) VS Industry: 31% outperformed.

-3.27

11.95

The dividend of **RNR** is growing, but earnings are growing more, so the dividend growth is sustainable.

The dividend of **RNR** has a limited annual growth rate of **4.49%**.

With a yearly dividend of 0.78%, **RNR** is not a good candidate for dividend investing.

With a **Dividend Yield** of **0.78**, **RNR** pays less dividend than the industry average, which is at **2.80**. 92% of the companies listed in the same industry pay a better dividend than **RNR**!

With a **Dividend Yield** of **0.78**, **RNR** pays less dividend than the S&P500 average, which is at **2.72**.

Dividend Yield (0.78%) VS Industry: 8% outperformed.

0.07

12.40

**RENAISSANCERE HOLDINGS LTD**

NYSE:RNR (5/26/2023, 6:49:58 PM)

After market: 190.02 +0.94 (+0.5%)**189.08**

**-5.59 (-2.87%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)05-02 2023-05-02/amc

Earnings (Next)07-24 2023-07-24/amc

Inst Owners81.37%

Inst Owner Change-4.09%

Ins Owners1.74%

Ins Owner Change8.62%

Market Cap9.50B

Analysts72.86

Price Target243.95 (29.02%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.78% |

Dividend Growth(5Y)4.49%

DP-67.97%

Div Incr Years19

Div Non Decr Years19

Ex-Date06-14 2023-06-14 (0.38)

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)12.48%

Min EPS beat(2)11.56%

Max EPS beat(2)13.39%

EPS beat(4)3

Avg EPS beat(4)3.28%

Min EPS beat(4)-18.6%

Max EPS beat(4)13.39%

Revenue beat(2)2

Avg Revenue beat(2)22.42%

Min Revenue beat(2)21.3%

Max Revenue beat(2)23.54%

Revenue beat(4)2

Avg Revenue beat(4)-2.27%

Min Revenue beat(4)-42.85%

Max Revenue beat(4)23.54%

PT rev (1m)-0.14%

PT rev (3m)6.06%

EPS NQ rev (1m)-1.98%

EPS NQ rev (3m)13.61%

EPS NY rev (1m)0%

EPS NY rev (3m)8.19%

Revenue NQ rev (1m)-12.07%

Revenue NQ rev (3m)-3.39%

Revenue NY rev (1m)0%

Revenue NY rev (3m)6%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.12 | ||

Fwd PE | 6.53 | ||

P/S | 1.48 | ||

P/FCF | 5.08 | ||

P/OCF | 5.08 | ||

P/B | 1.62 | ||

P/tB | 1.69 | ||

EV/EBITDA | N/A |

EPS(TTM)11.73

EY6.2%

EPS(NY)28.95

Fwd EY15.31%

FCF(TTM)37.25

FCFY19.7%

OCF(TTM)37.25

OCFY19.7%

SpS127.77

BVpS116.77

TBVpS112.06

PEG (NY)0.06

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | N/A | ||

ROE | N/A | ||

ROIC | 0.34% | ||

ROICexc | 0.35% | ||

ROICexgc | 0.42% | ||

OM | 2.52% | ||

PM | N/A | ||

GM | N/A |

ROICexgc(3y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc(3y)N/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.17

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.19 | ||

Debt/FCF | 0.61 | ||

Debt/EBITDA | N/A | ||

Cap/Depr | N/A | ||

Profit Quality | N/A | ||

Current Ratio | 0.69 | ||

Quick Ratio | 0.69 | ||

Altman-Z | 0.52 |

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y140.86%

EPS 3Y-8.37%

EPS 5YN/A

EPS growth Q2Q133.14%

EPS Next Y258.79%

EPS Next 2Y102.36%

EPS Next 3Y66.6%

EPS Next 5YN/A

Revenue growth 1Y3.44%

Revenue growth 3Y6.87%

Revenue growth 5Y19.63%

Revenue growth Q2Q146.03%

Revenue Next Year24.53%

Revenue Next 2Y13.98%

Revenue Next 3Y12.86%

Revenue Next 5YN/A

EBIT growth 1Y136.93%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y8.55%

FCF growth 3Y-9.13%

FCF growth 5Y9.35%

OCF growth 1Y8.55%

OCF growth 3Y-9.13%

OCF growth 5Y9.35%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*